Idexx Laboratories Inc.
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
4.32%
Market Cap
37.33 Bil.
P/E Ratio
51.74
Dividend Yield
0.00 %
Earnings per Share
11.59 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 482.4 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:55:51 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 482.6 | 470.4 |
| PREV. DAY'S PRICE | 473.2 | (06/02) |
| CHANGE DAY BEFORE | +9.20 | 1.94 % |
| 52 WEEK HIGH / LOW | 662.2 (11/25) | 440.3 (07/21) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 14.14 | 12.59 | 11.59 | 9.86 | 9.31 |
| DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | 34.43 | 38.67 | 51.74 | 38.76 | 55.16 |
| PRICE - BOOK RATIO | - | - | 33.59 | 21.15 | 31.04 |
| PRICE - SALES RATIO | - | - | 12.74 | 8.83 | 12.73 |
| PRICE - CASH FLOW RATIO | - | - | 46.53 | 37.05 | 51.42 |
Master Data
| WKN | 888210 |
| ISIN | US45168D1046 |
| SYMBOL | IX1 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | IDEXX Laboratories |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 78.88 Mil. |
| MARKET CAPITALISATION | 37.33 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -1.27 % | -0.90 % | -13.05 % | -25.06 % | 4.32 % | 7.79 % | 5.70 % | -18.64 % |
| HIGH | 490.50 | 498.00 | 558.40 | 628.40 | 662.20 | 662.20 | 662.20 | 620.40 |
| LOW | 468.50 | 445.40 | 445.40 | 445.40 | 440.30 | 325.20 | 309.45 | 445.40 |
Dividend
per share
IDEXX Laboratories does not deliver dividend information
Company profile
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Structured products for Idexx Laboratories Inc.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.